Stockreport

SpyGlass Pharma Announces Pricing of Initial Public Offering

SCHERING-PLOUGH CORP  (SGP) 
PDF ALISO VIEJO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced [Read more]